Section Arrow
Quote
PLSM.NASDAQ
- Pulsenmore Ltd.
Quotes are at least 15-min delayed:2026/05/11 12:57 EDT
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
3.75 
1-M High
3.98 
Volume 
-- 
Bid
3.5
Ask
3.97
Day Low
-- 
Open
-- 
1-M Low
3.0001 
Market Cap 
-- 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.48 
20-SMA 3.52 
50-SMA 3.86 
52-W High 10.28 
52-W Low 3.0001 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.46/--
Enterprise Value
542.00K
Balance Sheet
Book Value Per Share
4.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
40.02M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
WOKWORK Medical Technology Group LTD.0.85-0.43-33.59%-- 
ABTAbbott Laboratories82.44-1.88-2.23%23.08PE
BSXBoston Scientific Corp53.52-0.41-0.76%22.37PE
MDTMedtronic plc74.79-1.36-1.79%20.88PE
QSIQuantum-Si0.9267+0.0201+2.22%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and PulsenmoreFC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.